Berkeley Capital Partners’s MiMedx Group MDXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-34,225
Closed -$432K 117
2017
Q4
$432K Buy
34,225
+953
+3% +$11.6K 0.28% 86
2017
Q3
$395K Sell
33,272
-1,266
-4% -$18.8K 0.26% 92
2017
Q2
$517K Sell
34,538
-15,928
-32% -$213K 0.35% 72
2017
Q1
$481K Buy
50,466
+10,924
+28% +$92.2K 0.33% 78
2016
Q4
$350K Buy
39,542
+15,661
+66% +$141K 0.25% 81
2016
Q3
$205K Buy
23,881
+553
+2% +$4.38K 0.15% 102
2016
Q2
$186K Buy
23,328
+1,217
+6% +$9.47K 0.13% 107
2016
Q1
$193K Buy
22,111
+988
+5% +$8.21K 0.14% 98
2015
Q4
$198K Buy
+21,123
New +$183K 0.16% 104

Other funds holding MDXG

Berkeley Capital Partners's MDXG Position: Q1 2018 in Review

Berkeley Capital Partners sold out of MiMedx Group (MDXG) in Q1 2018, closing a stake of 34,225 shares — an estimated $432K sold.

Berkeley Capital Partners first reported a position in MDXG in Q4 2015 and held it in 9 quarters. The position peaked at $517K in Q2 2017. 223 funds tracked by Wall St. Rank hold MDXG as of Q1 2018.

  • Berkeley Capital Partners reported no remaining MiMedx Group position as of Q1 2018 after selling out during the quarter.
  • Berkeley Capital Partners sold 34,225 MiMedx Group shares in Q1 2018, an estimated $432K.
  • Berkeley Capital Partners first reported a position in MiMedx Group in Q4 2015 and held it in 9 quarters.
  • Berkeley Capital Partners's MiMedx Group position peaked at $517K in Q2 2017.
  • 223 funds tracked by Wall St. Rank held MiMedx Group as of Q1 2018.

Based on Berkeley Capital Partners's 13F filing for Q1 2018, filed 27 Apr 2018.